CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotyping von Bras, Anne E., Haas, Valerie, Stigt, Arthur, Jongen‐Lavrencic, Mojca, Beverloo, H. Berna, Marvelde, Jeroen G., Zwaan, C. Michel, Dongen, Jacques J.M., Leusen, Jeanette H.W., Velden, Vincent H.J.

Volltext

Standardised immunophenotypic analysis of myeloperoxidase in acute leukaemia von Bras, Anne E., Osmani, Zgjim, Haas, Valerie, Jongen‐Lavrencic, Mojca, te Marvelde, Jeroen G., Zwaan, C. Michel, Mejstrikova, Ester, Fernandez, Paula, Szczepanski, Tomasz, Orfao, Alberto, Dongen, Jacques J. M., Velden, Vincent H. J.

Volltext

Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome von Grob, Tim, Al Hinai, Adil S.A., Sanders, Mathijs A., Kavelaars, François G., Rijken, Melissa, Gradowska, Patrycja L., Biemond, Bart J., Breems, Dimitri A., Maertens, Johan, van Marwijk Kooy, Marinus, Pabst, Thomas, de Weerdt, Okke, Ossenkoppele, Gert J., van de Loosdrecht, Arjan A., Huls, Gerwin A., Cornelissen, Jan J., Beverloo, H. Berna, Löwenberg, Bob, Jongen-Lavrencic, Mojca, Valk, Peter J.M.

Volltext

The Oncogenic MicroRNA miR-22 Targets the TET2 Tumor Suppressor to Promote Hematopoietic Stem Cell Self-Renewal and Transformation von Song, Su Jung, Ito, Keisuke, Ala, Ugo, Kats, Lev, Webster, Kaitlyn, Sun, Su Ming, Jongen-Lavrencic, Mojca, Manova-Todorova, Katia, Teruya-Feldstein, Julie, Avigan, David E., Delwel, Ruud, Pandolfi, Pier Paolo

Volltext

The non-coding RNA landscape of human hematopoiesis and leukemia von Schwarzer, Adrian, Emmrich, Stephan, Schmidt, Franziska, Beck, Dominik, Ng, Michelle, Reimer, Christina, Adams, Felix Ferdinand, Grasedieck, Sarah, Witte, Damian, Käbler, Sebastian, Wong, Jason W. H., Shah, Anushi, Huang, Yizhou, Jammal, Razan, Maroz, Aliaksandra, Jongen-Lavrencic, Mojca, Schambach, Axel, Kuchenbauer, Florian, Pimanda, John E., Reinhardt, Dirk, Heckl, Dirk, Klusmann, Jan-Henning

Volltext

Prognostic Value of FLT3 -Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia von Grob, Tim, Sanders, Mathijs A, Vonk, Christian M, Kavelaars, Franҫois G, Rijken, Melissa, Hanekamp, Diana W, Gradowska, Patrycja L, Cloos, Jacqueline, Fløisand, Yngvar, van Marwijk Kooy, Marinus, Manz, Markus G, Ossenkoppele, Gert J, Tick, Lidwine W, Havelange, Violaine, Löwenberg, Bob, Jongen-Lavrencic, Mojca, Valk, Peter J M

Volltext

Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients von Huls, Gerwin, Chitu, Dana A., Havelange, Violaine, Jongen-Lavrencic, Mojca, van de Loosdrecht, Arjan A., Biemond, Bart J., Sinnige, Harm, Hodossy, Beata, Graux, Carlos, Kooy, Rien van Marwijk, de Weerdt, Okke, Breems, Dimitri, Klein, Saskia, Kuball, Jürgen, Deeren, Dries, Terpstra, Wim, Vekemans, Marie-Christiane, Ossenkoppele, Gert J., Vellenga, Edo, Löwenberg, Bob

Volltext

PPM1D mutations appear in complete remission after exposure to chemotherapy without predicting emerging AML relapse von Al Hinai, Adil S. A., Grob, Tim, Rijken, Melissa, Kavelaars, François G., Zeilemaker, Annelieke, Erpelinck-Verschueren, Claudia A. J., Sanders, Mathijs A., Löwenberg, Bob, Jongen-Lavrencic, Mojca, Valk, Peter J. M.

Volltext

CD38 expression in paediatric leukaemia and lymphoma: implications for antibody targeted therapy von Bras, Anne E., Beishuizen, Auke, Langerak, Anton W., Jongen‐Lavrencic, Mojca, Marvelde, Jeroen G., Heuvel‐Eibrink, Marry M., Zwaan, C. Michel, Dongen, Jacques J. M., Velden, Vincent H. J.

Volltext

MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia von Jongen-Lavrencic, Mojca, Sun, Su Ming, Dijkstra, Menno K., Valk, Peter J.M., Löwenberg, Bob

Volltext

Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia von Hirsch, Susanne, Blätte, Tamara J, Grasedieck, Sarah, Cocciardi, Sibylle, Rouhi, Arefeh, Jongen-Lavrencic, Mojca, Paschka, Peter, Krönke, Jan, Gaidzik, Verena I, Döhner, Hartmut, Schlenk, Richard F, Kuchenbauer, Florian, Döhner, Konstanze, Dolnik, Anna, Bullinger, Lars

Volltext

P494: A FIRST‐IN‐HUMAN STUDY OF CD123 NK CELL ENGAGER SAR443579 IN RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA, B‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA OR HIGH RISK‐MYELODYSPLASIA... von Selwyn Stein, Anthony, Jongen‐Lavrencic, Mojca, Garciaz, Sylvain, A Huls, Gerwin, Maiti, Abhishek, Boissel, Nicolas, De Botton, Stephane, Fleming, Shaun, Michel Zwaan, C., C. de Leeuw, David, Desai, Pinkal, Lucia Arellano, Martha, Avigan, David, Langemeijer, Saskia, Jensen, Kyle, Wagenaar, Timothy, MI, Gu, Abbadessa, Giovanni, Bajel, Ashish

Volltext

PB1887: STING AGONIST FOR THE TREATMENT OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH‐RISK MYELODYSPLASTIC SYNDROME: A FIRST‐IN‐CLINIC PHASE 1 STUDY OF GSK3745417 von Montesinos, Pau, Al‐Ali, Haifa Kathrin, Dominguez, Juan Manuel Alonso, Jentzsch, Madlen, Lavrencic, Mojca, Martelli, Maria Paola, Röllig, Christoph, Sica, Simona, Riham, Iadevaia, Yablonski, Kaitlin, Wang, Tianli, Mahmood, Zafar, Koenen, Giedre, Schmidt, Hank, Yang, Jingsing, Yee, Karen

Volltext

MiR-17/20/93/106 promote hematopoietic cell expansion by targeting sequestosome 1–regulated pathways in mice von Meenhuis, Annemarie, van Veelen, Peter A., de Looper, Hans, van Boxtel, Nicole, van den Berge, Iris J., Sun, Su M., Taskesen, Erdogan, Stern, Patrick, de Ru, Arnoud H., van Adrichem, Arjan J., Demmers, Jeroen, Jongen-Lavrencic, Mojca, Löwenberg, Bob, Touw, Ivo P., Sharp, Phillip A., Erkeland, Stefan J.

Volltext

The long non-coding RNA Cancer Susceptibility 15 is induced by Isocitrate Dehydrogenase mutations and maintains an immature phenotype in adult acute myeloid leukemia von Grasedieck, Sarah, Ruess, Christoph, Krowiorz, Kathrin, Lux, Susanne, Pochert, Nicole, Schwarzer, Adrian, Klusmann, Jan-Henning, Jongen-Lavrencic, Mojca, Herold, Tobias, Bullinger, Lars, Pollack, Jonathan R, Rouhi, Arefeh, Kuchenbauer, Florian

Volltext

Trends in incidence, primary treatment and survival in chronic myelomonocytic leukaemia: a population‐based study of 1359 patients diagnosed in the Netherlands from 1989 to 2012 von Dinmohamed, Avinash G., Brink, Mirian, Visser, Otto, Sonneveld, Pieter, Loosdrecht, Arjan A., Jongen‐Lavrencic, Mojca, Greef, Georgine E.

Volltext

Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study von Löwenberg, Bob, Beck, Joachim, Graux, Carlos, van Putten, Wim, Schouten, Harry C., Verdonck, Leo F., Ferrant, Augustin, Sonneveld, Pieter, Jongen-Lavrencic, Mojca, von Lilienfeld-Toal, Marie, Biemond, Bart J., Vellenga, Edo, Breems, Dimitri, de Muijnck, Hilde, Schaafsma, Ron, Verhoef, Gregor, Döhner, Hartmut, Gratwohl, Alois, Pabst, Thomas, Ossenkoppele, Gert J., Maertens, Johan, for the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON), German Austrian AML Study Group (AMLSG), Swiss Group for Clinical Cancer Research Collaborative Group (SAKK)

Volltext

Transition of highly specific microRNA expression patterns in association with discrete maturation stages of human granulopoiesis von Sun, Su M., Dijkstra, Menno K., Bijkerk, André C., Brooimans, Rik A., Valk, Peter J. M., Erkeland, Stefan J., Löwenberg, Bob, Jongen‐Lavrencic, Mojca

Volltext

Molecular Minimal Residual Disease in Acute Myeloid Leukemia von Jongen-Lavrencic, Mojca, Grob, Tim, Hanekamp, Diana, Kavelaars, François G, al Hinai, Adil, Zeilemaker, Annelieke, Erpelinck-Verschueren, Claudia A.J, Gradowska, Patrycja L, Meijer, Rosa, Cloos, Jacqueline, Biemond, Bart J, Graux, Carlos, van Marwijk Kooy, Marinus, Manz, Markus G, Pabst, Thomas, Passweg, Jakob R, Havelange, Violaine, Ossenkoppele, Gert J, Sanders, Mathijs A, Schuurhuis, Gerrit J, Löwenberg, Bob, Valk, Peter J.M

Volltext

The versatile nature of miR-9/9 in human cancer von Nowek, Katarzyna, Wiemer, Erik A C, Jongen-Lavrencic, Mojca

Volltext